Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers
International Journal of Radiation Oncology*Biology*Physics · 2026
DOI: 10.1016/j.ijrobp.2025.12.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Pippa F Cosper und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin; University of Wisconsin Carbone Cancer Center, University of Wisco…. Hauptthemen laut MEDLINE: Chromosomal Instability, Radiation Tolerance, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
PURPOSE: Continuous chromosome missegregation over successive mitotic divisions, known as chromosomal instability (CIN), is common in cancer. Though it has been associated with treatment resistance and poor prognosis, increasing CIN above a maximally tolerated threshold leads to cell death because of loss of essential chromosomes. Because radiation causes CIN, we hypothesize that pre-existing CIN sensitizes tumor cells to radiation therapy. METHODS AND MATERIALS: We induced mitotic defects that lead to CIN in FaDu (head and neck cancer, HNC) and HeLa (cervical) cells by knocking down or overexpressing the mitotic checkpoint protein mitotic arrest deficient 1 (Mad1), which induces lagging chromosomes. Radiation sensitivity was tested with clonogenic assays in vitro and tumor regression in patient-derived xenografts in vivo. MTT assays were used to determine the sensitivity of human papillomavirus (HPV) positive and HPV-negative HNC cells to docetaxel, and mitotic defects were quantified using immunofluorescence microscopy. Docetaxel-induced mitotic errors and tumor growth delay were evaluated in vivo. Six-chromosome fluorescence in situ hybridization was used to quantify CIN in a cohort of patients with laryngeal cancer treated with definitive radiation. RESULTS: Here, we show in two tissue contexts using engineered isogenic cancer cell lines that higher rates of chromosome missegregation sensitize to ionizing radiation, which itself induces mitotic errors. Consistent with this result, higher rates of anaphase defects in HPV-positive and HPV-negative HNC patient-derived xenograft tumors correlate with response to radiation. Moreover, laryngeal tumors with higher CIN before treatment tend to have an improved response to radiation therapy in the clinic. Furthermore, we show that docetaxel, a microtubule-stabilizing drug commonly used in combination with radiation, causes cell death and radiosensitizes cells by inducing abnormal multipolar spindles rather than causing mitotic arrest. CONCLUSIONS: These results mechanistically implicate CIN as an inducer of radiation response and provide evidence that increasing the rate of CIN is a rational method to enhance radiation sensitivity, which has significant implications for personalized therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin; University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin. Electronic address: cosper@wisc.edu.
- Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin.
- Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin, Madison, Wisconsin.
- Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison, Wisconsin.
- Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin.
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- Conquer Cancer Foundation
- RSNA Research and Educational Foundation
- American Society of Clinical Oncology
Zitieren
APA
Cosper, P. F., Paracha, M., Jones, K. M., Hrycyniak, L., Henderson, L., Bryan, A., Eyzaguirre, D., McCunn, E., Boulanger, E., Wan, J., Nickel, K. P., Horner, V., Hu, R., Harari, P. M., Kimple, R. J., & Weaver, B. A. (2026). Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.12.014
Vancouver
Cosper PF, Paracha M, Jones KM, Hrycyniak L, Henderson L, Bryan A, et al. Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2025.12.014
BibTeX
@article{Cosper2026,
author = {Cosper, Pippa F and Paracha, Maha and Jones, Kathryn M and Hrycyniak, Laura and Henderson, Les and Bryan, Ava and Eyzaguirre, Diego and McCunn, Emily and Boulanger, Elizabeth and Wan, Jun and Nickel, Kwangok P and Horner, Vanessa and Hu, Rong and Harari, Paul M and Kimple, Randall J and Weaver, Beth A},
title = {Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
doi = {10.1016/j.ijrobp.2025.12.014}
}
EUVIMED